Skip to main content
. 2019 Nov 26;2019(11):CD009286. doi: 10.1002/14651858.CD009286.pub3

Xie 2005.

Methods Aim: to study the effect of treatment with sertraline in elderly patients with post‐stroke depression
Parallel study
Participants Country: China
Setting: unclear
Recruited "clinically stable stroke patients with post‐stroke depression"
No other inclusion and exclusion criteria given
Mood: Zung SDS score ≥ 40 or GDS score 5 to 10
Treatment: 65 people, mean age 69.8 years, 29 men
Control: 65 people, mean age 70.7 years, 27 men
Time since stroke: mean 87.8 days, range 48 to 142 days
Interventions Treatment: sertraline 50 mg/day plus usual stroke care
Control: usual stroke care
Duration of treatment: 12 weeks
Duration of follow‐up: 0
Outcomes Zung SDS, GDS, ADL score
AEs were not reported
Funding source Local scientific academic fund funded the study
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) 
 All outcomes High risk No placebo
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not described
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No dropouts
Selective reporting (reporting bias) Unclear risk No protocol
Other bias Unclear risk No clear description between treatment and control